SETD2 and cancer: Gaofeng Xiong et al. suggested that P4HA1 promotes chemoresistance by modulating HIF-1-dependent cancer cell stemness, and targeting collagen P4H is a promising strategy to inhibit tumor progression and sensitize TNBC to chemotherapeutic agents (39).